Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (81-90 of 286) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profilingLloyd T Lam, R Eric Davis, Jackie Pierce, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Cell Reports|September 30, 2025
Biphasic control of the B cell transcriptome by mTORC1 and GSK3Jens Kalchschmidt, Tomoya Kanno, Solji Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomasMarta Cuadros, Sandeep S Dave, Elaine S Jaffe, et al.
Nature|March 31, 2006
A loss-of-function RNA interference screen for molecular targets in cancerVu N Ngo, R Eric Davis, Laurence Lamy, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2002
Stereotyped and specific gene expression programs in human innate immune responses to bacteriaJennifer C Boldrick, Ash A Alizadeh, Maximilian Diehn, et al.
Cancer Research|July 18, 2024
Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid LeukemiaConstanze Schneider, Hermes Spaink, Gabriela Alexe, et al.
The Journal of Experimental Medicine|December 2, 2015
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancyPriscilla N Kelly, Donna L Romero, Yibin Yang, et al.
The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
Blood|December 18, 2010
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expressionChristina M Annunziata, Lidia Hernandez, R Eric Davis, et al.
Pageof 29

Showing results (81-90 of 286) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profilingLloyd T Lam, R Eric Davis, Jackie Pierce, et al.
Blood|December 28, 2007
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphomaLloyd T Lam, George Wright, R Eric Davis, et al.
Cell Reports|September 30, 2025
Biphasic control of the B cell transcriptome by mTORC1 and GSK3Jens Kalchschmidt, Tomoya Kanno, Solji Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomasMarta Cuadros, Sandeep S Dave, Elaine S Jaffe, et al.
Nature|March 31, 2006
A loss-of-function RNA interference screen for molecular targets in cancerVu N Ngo, R Eric Davis, Laurence Lamy, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2002
Stereotyped and specific gene expression programs in human innate immune responses to bacteriaJennifer C Boldrick, Ash A Alizadeh, Maximilian Diehn, et al.
Cancer Research|July 18, 2024
Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid LeukemiaConstanze Schneider, Hermes Spaink, Gabriela Alexe, et al.
The Journal of Experimental Medicine|December 2, 2015
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancyPriscilla N Kelly, Donna L Romero, Yibin Yang, et al.
The New England Journal of Medicine|November 15, 2013
Low-intensity therapy in adults with Burkitt's lymphomaKieron Dunleavy, Stefania Pittaluga, Margaret Shovlin, et al.
Blood|December 18, 2010
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expressionChristina M Annunziata, Lidia Hernandez, R Eric Davis, et al.
Pageof 29